Hepatic overexpression of hemopexin inhibits inflammation and vascular stasis in murine models of sickle cell disease

Molecular Medicine

Volumn 22, Issue , 2016, Pages 437-451

  Vercellotti, Gregory M ^a,b   Zhang, Ping ^a,b   Nguyen, Julia ^a,b   Abdulla, Fuad ^a,b   Chen, Chunsheng ^a,b   Nguyen, Phong ^a,b   Nowotny, Carlos ^a,b   Steer, Clifford J ^a   Smith, Ann ^c   Belcher, John D ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEME OXYGENASE 1; HEMOPEXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LUCIFERASE; RINGER LACTATE SOLUTION; SCAVENGER RECEPTOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; INFLAMMATION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN OVEREXPRESSION; SICKLE CELL ANEMIA; SKINFOLD; TRANSPOSON; VENOUS STASIS;

EID: 84987657125     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2016.00063     Document Type: Article

References (79)

1. Bunn HF, Jandl JH. (1968) Exchange of heme among hemoglobins and between hemoglobin and albumin. J. Biol. Chem. 243:465-75.
2. Belcher JD, et al. (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 123:377-90.
3. Umbreit J. (2007) Methemoglobin-it’s not just blue: a concise review. Am. J. Hematol. 82:134-44.
4. Camus SM, et al. (2015) Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood. 125:3805-14.
5. Wagener FA, Abraham NG, van Kooyk Y, de Witte T, Figdor CG. (2001) Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation. Trends Pharmacol. Sci. 22:52-54.
6. Yamauchi T, Lin Y, Sharp FR, Noble-Haeusslein LJ. (2004) Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord. J. Neurotrauma. 21:1017-30.
7. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, Jacob HS. (1991) Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 64:648-55.
8. Jeney V, et al. (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood. 100:879-87.
9. Figueiredo RT, et al. (2007) Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282:20221-29.
10. Ghosh S, et al. (2013) Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J. Clin. Invest. 123:4809-20.
11. Kaul DK, Hebbel RP. (2000) Hypoxia/reoxygen-ation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106:411-20.
12. Kaul DK, et al. (2004) Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am. J. Physiol. Heart Circ. Physiol. 287: H293-301.
13. Kaul DK, et al. (2000) Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 95:368-74.
14. Frenette PS. (2004) Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation. 11:167-77.
15. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. (2002) Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. U.S.A. 99:3047-51.
16. Parise LV, Telen MJ. (2003) Erythrocyte adhesion in sickle cell disease. Curr. Hematol. Rep. 2:102-08.
17. Telen MJ. (2007) Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematology Am. Soc. Hematol. Educ. Program. 84-90.
18. Berberat PO, et al. (2003) Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 17:1724-26.
19. Otterbein LE, Soares MP, Yamashita K, Bach FH. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449-55.
20. Balla G, et al. (1992) Ferritin: a cytoprotective antioxidant stratagem of endothelium. J. Biol. Chem. 267:18148-53.
21. Belcher JD, et al. (2006) Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest. 116:808-16.
22. Vercellotti GM, et al. (2014) H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice. Front. Pharmacol. 5:79.
23. Alam J, Smith A. (1989) Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J. Biol. Chem. 264:17637-40.
24. Smith A, Morgan WT. (1979) Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem. J. 182:47-54.
25. Moestrup SK, Moller HJ. (2004) CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 36:347-54.
26. Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. (2013) Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 121:1276-84.
27. Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M. (1968) Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 32:811-15.
28. Fagoonee S, et al. (2005) Plasma Protein Haptoglobin Modulates Renal Iron Loading. Am. J. Pathol. 166:973-83.
29. Li RC, et al. (2009) Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J. Cereb. Blood Flow Metab. 29:953-64.
30. Vinchi F, et al. (2016) Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Blood. 127:473-86.
31. Vinchi F, et al. (2013) Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases. Circulation. 127(12):1317-29.
32. Vinchi F, Gastaldi S, Silengo L, Altruda F, Tolosano E. (2008) Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am. J. Pathol. 173:289-99.
33. Baek JH, et al. (2012) Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J. Clin. Invest. 122:1444-58.
34. Boretti FS, et al. (2009) Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J. Clin. Invest. 119:2271-80.
35. Tolosano E, et al. (1999) Defective recovery and severe renal damage after acute hemolysis in he-mopexin-deficient mice. Blood. 94:3906-14.
36. Smith A, McCulloh RJ. (2015) Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front. Physiol. 6:187.
37. Hvidberg V, et al. (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood. 106:2572-79.
38. Fabry ME, Nagel RL, Pachnis A, Suzuka SM, Costantini F. (1992) High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc. Natl. Acad. Sci. U.S.A. 89:12150-54.
39. Wu LC, et al. (2006) Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 108:1183-88.
40. Belcher JD, Nath KA, Vercellotti GM. (2013) Vasculotoxic and pro-inflammatory effects of plasma heme: Cell signaling and cytoprotective responses. ISRN Oxid. Med. 2013: Article ID 831596.
41. Chen L, Zhang X, Chen-Roetling J, Regan RF. (2011) Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J. Neurosurg. 114:1159-67.
42. Wilber A, et al. (2006) RNA as a source of trans-posase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Mol. Ther. 13:625-30.
43. Xue X, et al. (2009) Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood. 114:1319-30.
44. Paoli M, et al. (1999) Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat. Struct. Biol. 6:926-31.
45. Bell JB, et al. (2007) Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection. Nat. Protoc. 2:3153-65.
46. Belcher JD, et al. (2010) Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J. Mol. Med. (Berl.) 88:665-75.
47. Longo PA, Kavran JM, Kim MS, Leahy DJ. (2014) Single cell cloning of a stable mammalian cell line. Methods Enzymol. 536:165-72.
48. Aydin H, Azimi FC, Cook JD, Lee JE. (2012) A convenient and general expression platform for the production of secreted proteins from human cells. JoVE.
49. Morgan WT, et al. (1988) Use of hemopexin domains and monoclonal antibodies to hemopexin to probe the molecular determinants of hemo-pexin-mediated heme transport. J. Biol. Chem. 263:8220-25.
50. Fairbanks VF, Ziesmer SC, O’Brien PC. (1992) Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin. Chem. 38:132-40.
51. Kalambur VS, et al. (2004) Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am. J. Hematol. 77:117-25.
52. Morgan WT, Liem HH, Sutor RP, Muller-Eberhard U. (1976) Transfer of heme from heme-albumin to hemopexin. Biochim. Biophys. Acta. 444:435-45.
53. Morgan WT, et al. (1993) Identification of the histidine residues of hemopexin that coordinate with heme-iron and of a receptor-binding region. J. Biol. Chem. 268:6256-62.
54. Alam J, et al. (1999) Nrf2, a Cap’n′Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274:26071-78.
55. Alam J, et al. (2000) Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J. Biol. Chem. 275:27694-702.
56. Chorley BN, et al. (2012) Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 40:7416-29.
57. Walsh J, et al. (2014) Identification and quantifi-cation of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications. J. Proteomics. 108:171-87.
58. Shen G, et al. (2006) Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer che-mopreventive agent curcumin. Mol. Cancer Ther. 5:39-51.
59. Ishii T, et al. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275:16023-29.
60. Boyle JJ, et al. (2011) Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 31: 2685-91.
61. Tsuji Y, et al. (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol. Cell. Biol. 20:5818-27.
62. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. (2014) Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front. Physiol. 5:415.
63. Mollan TL, et al. (2014) Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin. Free Radic. Biol. Med. 69:265-77.
64. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11:1700-11.
65. Balla J, et al. (1993) Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 90:9285-89.
66. Balla J, et al. (2000) Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood. 95:3442-50.
67. Balla J, Jacob HS, Balla G, Nath K, Vercellotti GM. (1992) Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans. Assoc. Am. Physicians. 105:1-6.
68. Balla J, et al. (1995) Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am. J. Physiol. 268: L321-27.
69. Alam J, et al. (2003) Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am. J. Physiol. Renal Physiol. 284: F743-52.
70. Balogun E, et al. (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371:887-95.
71. Choi AM, Alam J. (1996) Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15:9-19.
72. Li N, et al. (2004) Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol. 173:3467-81.
73. Nath KA, et al. (2000) The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156:1527-35.
74. Thimmulappa RK, et al. (2002) Identification of Nrf2-regulated genes induced by the chemopre-ventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196-203.
75. Dutra FF, et al. (2014) Hemolysis-induced lethal-ity involves inflammasome activation by heme. Proc. Natl. Acad. Sci. U.S.A. 111: E4110-18.
76. Belcher JD, et al. (2016) Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate. Antioxid. Redox Signal. [Epub ahead of print 2016 Mar 30].
77. Keleku-Lukwete N, et al. (2015) Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation. Proc. Natl. Acad. Sci. U.S.A. 112:12169-74.
78. Kristiansen M, et al. (2001) Identification of the haemoglobin scavenger receptor. Nature. 409:198-201.
79. Schaer DJ, Alayash AI. (2010) Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid. Redox Signal. 12:181-84.